Literature DB >> 22377101

MTR abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.

Georg Bohner1, Denny Milakara, Henning Witthaus, Jürgen Gallinat, Michael Scheel, Georg Juckel, Randolf Klingebiel.   

Abstract

BACKGROUND: Neuroimaging studies have suggested gray (GM) and white matter (WM) abnormalities in early stages of schizophrenia. We aimed at evaluating subtle parenchymal alterations in individuals at ultra-high risk (UHR) for transition into psychosis and first-episode schizophrenic (FES) patients by measuring the magnetization transfer ratio (MTR). METHODS AND MATERIAL: In a cross-sectional study magnetization transfer images and high-resolution volumetric T1-weighted images were acquired in 70 age- and gender-matched subjects (25 UHR subjects, 16 FES patients and 29 controls) in a 1.5Tesla scanner. Following normalization of MTR-maps the intensity histograms were analyzed by performing a Kruskal-Wallis-test.
RESULTS: Gray matter MTR decreases were depicted in UHR subjects solely, involving the cingulate gyrus and precentral cortex. WM MTR alterations were more pronounced in FES than in UHR patients and exclusively affected the frontal lobe bilaterally. In addition, UHR subjects showed bilateral MTR decreases at the stria terminalis though statistically significant only on the left side (p=0.018.)
CONCLUSION: Our results indicate GM affection earlier on during disease progression as well as cumulative WM affection within frontal lobes during transition from UHR to FES. MTR reductions at the stria terminalis of UHR patients points to the involvement of the extended amygdala in the prodromal disease stage.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22377101     DOI: 10.1016/j.schres.2012.01.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

Review 1.  Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings.

Authors:  Benjamin K Brent; Heidi W Thermenos; Matcheri S Keshavan; Larry J Seidman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-07-23

2.  Comparing free water imaging and magnetization transfer measurements in schizophrenia.

Authors:  René C W Mandl; Ofer Pasternak; Wiepke Cahn; Marek Kubicki; René S Kahn; Martha E Shenton; Hilleke E Hulshoff Pol
Journal:  Schizophr Res       Date:  2014-10-22       Impact factor: 4.939

Review 3.  Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?

Authors:  Anthony O Ahmed; Peter F Buckley; Mona Hanna
Journal:  Curr Psychiatry Rep       Date:  2013-03       Impact factor: 5.285

4.  Magnetization transfer imaging alterations and its diagnostic value in antipsychotic-naïve first-episode schizophrenia.

Authors:  Du Lei; Xueling Suo; Kun Qin; Walter H L Pinaya; Yuan Ai; Wenbin Li; Weihong Kuang; Su Lui; Graham J Kemp; John A Sweeney; Qiyong Gong
Journal:  Transl Psychiatry       Date:  2022-05-06       Impact factor: 7.989

5.  Metabolic Aberrations Impact Biophysical Integrity of Macromolecular Protein Pools in the Default Mode Network.

Authors:  Shaolin Yang; Minjie Wu; Olusola Ajilore; Melissa Lamar; Anand Kumar
Journal:  Diabetes       Date:  2016-08-19       Impact factor: 9.461

6.  Neural substrate of quality of life in patients with schizophrenia: a magnetisation transfer imaging study.

Authors:  Catherine Faget-Agius; Faget-Agius Catherine; Laurent Boyer; Jonathan Wirsich; Wirsich Jonathan; Jean-Philippe Ranjeva; Ranjeva Jean-Philippe; Raphaelle Richieri; Richieri Raphaelle; Elisabeth Soulier; Soulier Elisabeth; Sylviane Confort-Gouny; Confort-Gouny Sylviane; Pascal Auquier; Auquier Pascal; Maxime Guye; Guye Maxime; Christophe Lançon; Lançon Christophe
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

7.  Combined white matter imaging suggests myelination defects in visual processing regions in schizophrenia.

Authors:  Lena Palaniyappan; Ali Al-Radaideh; Olivier Mougin; Penny Gowland; Peter F Liddle
Journal:  Neuropsychopharmacology       Date:  2013-04-04       Impact factor: 7.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.